Landos Biopharma
Carolyn Y. has held various roles in the clinical research and quality assurance fields since 2002. Her career began as a Clinical Research Coordinator II at Massachusetts Eye & Ear Infirmary in 2002. Carolyn then moved to Parexel International in 2003 as a Clinical Data Manager. In 2004, they joined FutureSearch Trials as a QA/Clinical Research Manager and Sr. Certified Clinical Research Coordinator. In 2012, they joined PPD as a Clinical Research Associate II. In 2014, they joined The Coghlan Group Inc. as a QA Manager. In 2017, they were promoted to Director of Quality Assurance at The Coghlan Group Inc. (DBA: Caligor Coghlan Pharma Services). In 2019, they joined Caligor Coghlan as a Sr. Director Global Quality Assurance. In 2021, they moved to Repertoire Immune Medicines as a Director QA - GCP and is currently employed at Landos Biopharma, Inc. as Director GCP Quality Assurance.
Carolyn Y. holds a Master's degree in Public Administration from the University of Washington, a Bachelor's degree in Sociology from Brandeis University, and a Presidential Management Fellow from the US Department of State in International Relations and Affairs. Carolyn also holds a Certified Clinical Research Coordinator (CCRC) certification from ACRP, obtained in August 2006, and an RQAP certification from the Society of Quality Assurance.
This person is not in any offices
Landos Biopharma
Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune disease.